Cargando…
A field based evaluation of adverse events following MenAfriVac(®)vaccine delivered in a controlled temperature chain (CTC) approach in Benin
INTRODUCTION: An estimated one hundred million African meningitis belt residents have received MenAfriVac(®)meningococcal serogroup A conjugate vaccine. Since October 2012 the vaccine has been licensed for use in a controlled temperature chain (CTC) approach, at temperatures of up to 40°C for up to...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282804/ https://www.ncbi.nlm.nih.gov/pubmed/25574320 http://dx.doi.org/10.11604/pamj.2014.18.344.3975 |